FORM 4
[ ] Check this box if no longer
subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). (Print or Type Responses) |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response. . . . . 0.5 |
1. Name and Address of Reporting Person*
Hardwick, Charles L.
(Last) (First) (Middle)
Pfizer Inc. Att: Corporate Secretary
235 East 42nd Street
(Street)
New York, NY 10017
(City) (State) (Zip)
|
2. Issuer Name and Ticker or Trading Symbol Pfizer Inc (PFE)
|
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable) Director
10% Owner
X Officer
Other
Senior Vice President
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
|
|
3. I.R.S. Identification
Number of Reporting Person, if an entity (voluntary) |
4. Statement for Month/Day/Year December 18, 2002
5. If Amendment,
Date of Original (Month/Day/Year) |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1. Title of Security (Instr. 3) |
2. Transaction Date
(Month/Day/Year) |
2A. Deemed
Execution Date, if any (Month/Day/Year) |
3. Transaction Code and Voluntary Code (Instr. 8) Code | V
|
4. Securities Acquired (A) or Disposed (D) Of (Instr. 3, 4, and 5) Amount | A/D | Price
|
5. Amount of
Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) |
6. Owner-
ship Form: Direct(D) or Indirect (I) (Instr. 4) |
7. Nature of
Indirect Beneficial Ownership (Instr. 4) |
Common Stock
|
08/06/2002
|
|
L |
|
32 | A | $30.96
|
|
D
|
|
Common Stock
|
09/27/2002
|
|
L |
|
27(1) | A | $29.79
|
|
D
|
|
Common Stock
|
10/14/2002
|
|
L |
|
32 | A | $30.86
|
|
D
|
|
Common Stock
|
12/18/2002
|
|
S |
|
30(1) | D | $30.10
|
7,725 |
D
|
|
Common Stock
|
|
|
|
|
39,543 |
I
|
By Rule 16b-3 Plan
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
Persons who respond to the collection of information contained in this form are not required to
respond unless the form displays a currently valid OMB control number. |
(over)
SEC 1474 (9-02) |
Hardwick, Charles L. - December 18, 2002 |
Form 4 (continued) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security
(Instr. 3) |
2. Conver-
sion or Exercise Price of Deri- vative Security |
3. Transaction
Date (Month/ Day/ Year) |
3A. Deemed
Execution Date, if any (Month/ Day/ Year) |
4. Transaction
Code and Voluntary (V) Code (Instr.8) Code | V
|
5. Number of Derivative Securities Acquired (A) or Disposed (D) Of (Instr. 3,4 and 5) |
6. Date Exercisable(DE) and
Expiration Date(ED) (Month/Day/Year) (DE) | (ED)
|
7. Title and Amount of
Underlying Securities (Instr. 3 and 4) |
8. Price
of Derivative Security (Instr.5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transactions (Instr.4) |
10. Owner- ship Form of Deriv- ative Security: Direct (D) or Indirect (I) (Instr.4) |
11. Nature of Indirect Beneficial Ownership (Instr.4) |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. |
By: Margaret M. Foran for Charles L. Hardwick 02-14-2003 ** Signature of Reporting Person Date Power of Attorney Page 2
|
Hardwick, Charles L. - December 18, 2002 |
Form 4 (continued) |
FOOTNOTE Descriptions for Pfizer Inc (PFE) Form 4 - December 18, 2002
Charles L. Hardwick
Pfizer Inc. Att: Corporate Secretary 235 East 42nd Street New York, NY 10017 Explanation of responses: (1) Mr. Hardwick paid Pfizer Inc. $8.13 representing disgorgement of short-swing profit resulting from the purchase of 27 shares of Pfizer Inc. on September 27, 2002 at $29.79 per share (total purchase price of $804.57) and the sale of 27 shares of Pfizer Inc. on December 18, 2002 at $30.10 per share (total sale proceeds of $812.70). These purchases and sale transactions were effected by Mr. Hardwick's portfolio manager without his prior knowledge. |
Page 3 |